PPT-Cardiovascular and Diabetes Coalition of Indiana (CADI

March 11 2015 Community Outreach and Engagement IU Health 2013 2015 System Priorities How does IU Health impact the community Access to Healthcare Priority Update Im just happy with the fact that they found it early and nothing bad happened. Applying evidence based medicine to clinical care. Cardiovascular disease is the biggest killer in UK. Number. of . deaths. (000’s). 124,037. 60,666. 18,165. 33,634. 16,216. 12,762. 103,431. 19,996. DONATIONS. IRS Rules and Regs. and CADI’s Policies/Procedures. 1. Donations. If the donor . DOES NOT . want a tax donation. No problem – Take the $$. . Send a thank you note. . Use the money for the team. Democracy is not a spectator sport. ---. Carrie Chapman Catt. The thing about democracy, beloveds, is that it is not neat, orderly, or quiet. It requires a certain relish for confusion.. ---. DONATIONS. IRS Rules and Regs. and CADI’s Policies/Procedures. Tax-deductible GF Donations. Donations are NOT tax-deductible if:. Given to an individual. Donations are tax-deductible if:. MUST be given to a tax-exempt (501c3) organization.. INTEGRAL. Center . of. Integral . Assistance. & . Development. GLOBAL DNA FORUM. W. HO WE ARE? . A . Coalition.  . of. 11 Christian . organizations.  . working. . with. . shared. . mission. Deepak L. Bhatt, MD, MPH. Professor . of Medicine, Harvard Medical School. Executive Director of Interventional Cardiovascular Programs. Brigham & Women’s Hospital Heart and Vascular Center. Boston, Massachusetts. Cyrus Desouza, MD. October 22, 2017. Why?. 1A. Evaluate the effect of vitamin D supplementation on incident CVD in people with . pre-diabetes.. 1B. . Establish CVD . risk in people with . pre-diabetes, defined by the modern ADA criteria.. Antidiabetes. Medications:. Cardiovascular Benefits. Hengameh. . Abdi. Endocrine Research Center. Research Institute for Endocrine sciences. Shahid. . Beheshti. University of Medical Sciences. 13 December 2018. European Association for the Study of Diabetes. Lisbon, . 13. th. . September 2017. ISRCTN number: 91899513. ClinicalTrials.gov number: . NCT00829660. Study Rationale, Design and Conduct. The Diabetes Burden. David J Albrecht D.O.. Heart & Vascular 2018 Winter Conference. Cardiovascular risk . m. odification in relation to current diabetes management . therapies. Case study highlighting the therapeutic decisions . TECOS Executive Committee MemberRury R. Holman, MB, ChBDiabetes Trials Unit, OCDEM Churchill Hospital, Oxford, United KingdomTECOS CoPrincipal Investigator andJoint Chair of TECOS Executive CommitteeR and . Meglitinides. in CLINICAL DIABETES . F. . . Hadaegh. Jan. . 2017. 1/12/2017. AGENDA. 3. 1/12/2017. Available treatment algorithms for T. 2. DM. Basic and clinical points. Review on available literatures. Sex . Male. Diabetes. . History. T2D, . onset. @45 . yrs. , treatment: . metformin. , . sitagliptin. and . gliclazide. . Organ. . damage. . evaluation. :. Eyes. : No . signs. of . retinopathy. GGC MCN meeting 5. th. February 2019. John R Petrie. Professor of Diabetic Medicine. University of Glasgow, UK. Advisory and Consultancy Work:. Novo Nordisk, Sanofi-Aventis, Biocon, Astra Zeneca, . Servier.